Cardiovascular

Estimated Pulse Wave Velocity Is Associated with Early Renal Impairment in Non-Diabetic Hypertensive Patients.

TL;DR

ePWV is an independent risk marker for early renal impairment in non-diabetic hypertensive patients, supporting its potential use in early risk stratification.

Key Findings

Non-diabetic hypertensive patients with early renal impairment had significantly higher estimated pulse wave velocity than those without.

  • Study included 509 non-diabetic adults with essential hypertension in a retrospective design
  • Participants were classified as having early renal impairment (UACR ≥30 mg/g, n = 167) or not (UACR <30 mg/g, n = 342)
  • The impairment group showed significantly higher ePWV (P < 0.001)
  • ePWV was calculated from age and mean blood pressure (MBP)

Restricted cubic spline analysis revealed a positive linear correlation between ePWV and UACR.

  • P for nonlinearity = 0.938, confirming the relationship was linear rather than nonlinear
  • The association was positive, meaning higher ePWV corresponded to higher UACR values

Each 1 m/s increase in ePWV was independently associated with a 43.9% elevated risk of early renal impairment.

  • OR = 1.439 (95% CI: 1.176–1.761) per 1 m/s increase in ePWV
  • ePWV was identified as an independent risk factor via multivariable logistic regression
  • The highest ePWV quartile (>9.70 m/s) showed an OR of 4.894 (95% CI: 2.019–11.86) compared to the lowest quartile

ePWV demonstrated superior discriminatory ability for early renal impairment compared to age and mean blood pressure alone.

  • ROC analysis showed ePWV had the highest AUC at 0.710
  • AUC for age alone was 0.585 and for MBP alone was 0.693
  • ePWV provided greater incremental value for identifying early renal impairment than age and MBP when incorporated into the base model

The association between ePWV and early renal impairment was consistent across multiple subgroups.

  • Subgroup analyses were performed by sex, age, BMI, and eGFR
  • All subgroup analyses consistently supported the association between ePWV and early renal impairment
  • No significant effect modification by these subgroup variables was reported

What This Means

This research suggests that a measure of arterial stiffness called estimated pulse wave velocity (ePWV) — calculated simply from a person's age and blood pressure — is strongly linked to early kidney damage in people with high blood pressure who do not have diabetes. The study followed 509 such patients and found that those with signs of early kidney impairment (detected by protein leaking into urine) consistently had higher ePWV values. For every 1 m/s increase in ePWV, the odds of having early kidney damage rose by about 44%, and people in the highest ePWV group were nearly five times more likely to show kidney impairment than those in the lowest group. The study also found that ePWV was better at identifying patients with early kidney damage than either age or blood pressure measurements on their own, and adding ePWV to standard clinical information improved the ability to detect at-risk patients. Importantly, ePWV does not require any special equipment — it can be estimated from routine clinical measurements, making it a potentially accessible screening tool. This research suggests that routinely calculating ePWV in hypertensive patients without diabetes could help doctors identify those at risk for kidney damage earlier, potentially allowing for timelier intervention to slow or prevent progression to chronic kidney disease. The findings held up across different groups divided by sex, age, body weight, and kidney function, strengthening confidence in the association.

Have a question about this study?

Citation

Kamili K, Zhuo Y, Wang D, Xu S, Li X, Gao P, et al.. (2026). Estimated Pulse Wave Velocity Is Associated with Early Renal Impairment in Non-Diabetic Hypertensive Patients.. Journal of clinical hypertension (Greenwich, Conn.). https://doi.org/10.1111/jch.70295